- Research works
- 20 ▼ 82% vs 2013–17
- Citations
- 231 11.5 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 11% world 28%
Not ranked overall: ISO Arzneimittel (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at ISO Arzneimittel (Germany)?
By fractional works in all years, weighted toward what it does more of than the world: Antibiotic Resistance, Chronic Kidney Disease, Diabetes Mellitus, Obesity, Epidemiology, Treatment, Chronic Cough and Cough Reflex Sensitivity.
- Nontuberculous Mycobacteria
- Innate Immunity
- EEG Analysis
- Cystic Fibrosis
- Diagnosis
- Chronic Cough
- Treatment
- Diabetes Mellitus
- Antibiotic Resistance
- Epidemiology
- Chronic Kidney Disease
- Obesity
- Inflammation
- Cough Reflex Sensitivity
- Synthesis
- Brain-Computer Interfaces
- Imidazoles
- Mycobacterium avium
- Oxazolones
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 19 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 19 words, with their numbers
- Epidemiology3▲ 3.2×11 topics
- Antibiotic Resistance2▲ 26×4 topics
- Chronic Kidney Disease2▲ 43×2 topics
- Diabetes Mellitus2▲ 44×1 topic
- Obesity2▲ 13×1 topic
- Treatment2▲ 6.6×5 topics
- Inflammation2▲ 3.3×6 topics
- Chronic Cough2▲ 242×1 topic
- Cough Reflex Sensitivity2▲ 242×1 topic
- Diagnosis1▲ 6.5×2 topics
- Synthesis1▲ 11×2 topics
- Cystic Fibrosis1▲ 77×2 topics
- Brain-Computer Interfaces1▲ 66×1 topic
- EEG Analysis1▲ 66×1 topic
- Imidazoles1▲ 182×1 topic
- Innate Immunity1▲ 14×2 topics
- Mycobacterium avium1▲ 110×1 topic
- Nontuberculous Mycobacteria1▲ 110×1 topic
- Oxazolones1▲ 182×1 topic
Which research topics does ISO Arzneimittel (Germany) publish most on?
By volume in 2022–2025: Acne and Rosacea Treatments and Effects, Sympathectomy and Hyperhidrosis Treatments, Hair Growth and Disorders and Parkinson's Disease Mechanisms and Treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Acne and Rosacea Treatments and Effects Dermatology 0 works
- 2 Sympathectomy and Hyperhidrosis Treatments Physiology 0 works
- 3 Hair Growth and Disorders Urology 0 works
- 4 Parkinson's Disease Mechanisms and Treatments Neurology 0 works
- 5 Dementia and Cognitive Impairment Research Psychiatry and Mental health 0 works
- 6 Alzheimer's disease research and treatments Physiology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has ISO Arzneimittel (Germany)'s research output changed?
Output in 2018–2022 was 82% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Ettlingen
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.